Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of “Hold” by Brokerages

Definitive Healthcare Corp. (NASDAQ:DH) has received a consensus rating of “Hold” from the eleven ratings firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $5.81.

A number of brokerages recently commented on DH. BTIG Research began coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Morgan Stanley cut their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. Finally, Barclays cut their price objective on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a report on Wednesday, August 7th.

Definitive Healthcare Stock Down 1.5 %

Shares of DH opened at $4.67 on Wednesday. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62. The firm has a market cap of $539.48 million, a P/E ratio of -1.51, a price-to-earnings-growth ratio of 3.50 and a beta of 1.40. The firm’s 50-day simple moving average is $4.37 and its 200 day simple moving average is $4.77. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Institutional Trading of Definitive Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Massachusetts Financial Services Co. MA lifted its holdings in shares of Definitive Healthcare by 36.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after acquiring an additional 1,626,813 shares during the period. Vanguard Group Inc. increased its position in Definitive Healthcare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after purchasing an additional 67,068 shares in the last quarter. Millennium Management LLC acquired a new position in Definitive Healthcare during the 2nd quarter worth approximately $9,283,000. State Street Corp increased its position in Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after purchasing an additional 317,952 shares in the last quarter. Finally, Granite Investment Partners LLC increased its position in Definitive Healthcare by 22.5% during the 2nd quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock worth $4,831,000 after purchasing an additional 162,432 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.